SCHEMBL26633908

SCHEMBL26633908

COc1ccc(CNC(=O)NC2CC3(C2)CC(C(=O)N2CCN(Cc4ccccn4)CC2)C3)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ HRH3 Q9Y5N1 1/20 0.47
▸ MMP1 P03956 1/20 0.45
▸ MMP2 P08253 1/20 0.45
▸ MMP3 P08254 1/20 0.45
▸ MMP9 P14780 1/20 0.45
▸ MMP8 P22894 1/20 0.45
▸ MMP13 P45452 1/20 0.45
▸ MMP14 P50281 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ SCN9A Q15858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011321 0.90 MCHR1 (0.53) MCHR1MEN1KMT2AHRH3MMP1
SCHEMBL26633753 0.86 MCHR1 (0.54) MCHR1HRH3SMN1; SMN2NPC1RAB9A
SCHEMBL26633713 0.84 MCHR1 (0.51) MCHR1MEN1KMT2AHRH3SMN1; SMN2
SCHEMBL26764110 0.83 SMN1; SMN2 (0.57) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL30306645 0.83 SMN1; SMN2 (0.57) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL26633914 0.83 NPC1 (0.51) MCHR1MEN1KMT2AHRH3SMN1; SMN2
SCHEMBL26633940 0.82 SMN1; SMN2 (0.55) MCHR1MEN1KMT2AHRH3SMN1; SMN2
SCHEMBL26633880 0.82 SMN1; SMN2 (0.55) MCHR1MEN1KMT2AHRH3SMN1; SMN2
SCHEMBL26633731 0.82 SMN1; SMN2 (0.53) MCHR1HRH3SMN1; SMN2NPC1RAB9A
SCHEMBL26764143 0.81 SMN1; SMN2 (0.49) MCHR1MEN1KMT2AHRH3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed
EP-4146640-A2 NAMPT MODULATORS Cytokinetics, Inc. (US) 2023-03-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT MCHR1 360/4885MEN1 110/4885KMT2A 1973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback